Evidence map›Paper›PMID 42361044›Full record

Trial reportPloS one2026

Determinants of dropout from lifestyle interventions for overweight polycystic ovary syndrome: An exploratory analysis of randomized controlled trial.

Min Xie, Siyu Zhou, Jing Wu, Xiaoyan Luo, Yichuan Guo, Lin Qiao, Jing Zhang

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Min XieWest China Second University Hospital, Department of Obstetrics and Gynaecology, Sichuan University, Chengdu, China.ORCID https://orcid.org/0009-0009-5582-1563
Siyu ZhouWest China Second University Hospital, Department of Obstetrics and Gynaecology, Sichuan University, Chengdu, China.
Jing WuWest China Second University Hospital, Follow up centre, Sichuan University, Chengdu, China.
Xiaoyan LuoWest China Second University Hospital, Department of Obstetrics and Gynaecology, Sichuan University, Chengdu, China.
Yichuan GuoWest China Second University Hospital, Department of Obstetrics and Gynaecology, Sichuan University, Chengdu, China.
Lin QiaoWest China Second University Hospital, Department of Obstetrics and Gynaecology, Sichuan University, Chengdu, China.
Jing ZhangWest China Second University Hospital, Department of Obstetrics and Gynaecology, Sichuan University, Chengdu, China.ORCID https://orcid.org/0000-0002-1978-0030

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis exploratory analysis of a randomized controlled trial aimed to identify baseline predictors of dropout in overweight women with polycystic ovary syndrome (PCOS) participating in a lifestyle intervention program.

methodsAn exploratory analysis was conducted using data from a randomized controlled trial involving overweight or insulin-resistant women with PCOS aged 18-45. All participants received cyclic progestin, metformin, and a structured lifestyle intervention. Dropout was defined as proactive withdrawal, missing two consecutive visits, or loss of contact for more than six months. Univariate and adjusted multivariable logistic regression models were used to identify factors associated with dropout.

resultsAmong the participants, 61.06% (n = 69) dropped out within one year. No significant differences were observed in baseline demographic, clinical, biochemical, psychological, or dietary characteristics between completers and dropouts. However, baseline physical activity level (PAL), objectively measured using an accelerometer, was identified as the strongest predictor of dropout. Each 0.3-unit increase in PAL was associated with a 29.6% reduction in the likelihood of dropout.

conclusionBaseline PAL is strongly associated with the risk of dropout. Screening for PAL in women with PCOS is recommended, and those with lower PAL should receive personalized support in addition to lifestyle interventions to improve adherence and promote weight loss.

Indexed as

Life StyleOverweightPatient DropoutsPolycystic Ovary SyndromeAdolescentAdultExerciseFemaleHumansMetforminMiddle AgedYoung AdultMetformin

Identifiers

PMID42361044
PMCPMC13308866

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.